Credit Suisse’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $425K | Hold |
63,289
| – | – | ﹤0.01% | 2698 |
|
|
2023
Q4 | $372K | Sell |
63,289
-20,489
| -24% | -$120K | ﹤0.01% | 2850 |
|
|
2023
Q3 | $817K | Buy |
83,778
+4,201
| +5% | +$41K | ﹤0.01% | 2405 |
|
|
2023
Q2 | $942K | Buy |
79,577
+50,887
| +177% | +$603K | ﹤0.01% | 2404 |
|
|
2023
Q1 | $310K | Buy |
28,690
+2,702
| +10% | +$29.2K | ﹤0.01% | 2968 |
|
|
2022
Q4 | $300K | Buy |
25,988
+25,626
| +7,079% | +$296K | ﹤0.01% | 3026 |
|
|
2022
Q3 | $5K | Buy |
362
+320
| +762% | +$4.42K | ﹤0.01% | 3627 |
|
|
2022
Q2 | $0 | Buy |
+42
| New | – | ﹤0.01% | 3966 |
|